MTOR and glioma: A current report also JMJD2A depletion reduced protein synthesis and enhanced the protein synthesis suppression observed with mTOR inhibitors, which paralleled an increased sensitivity to drugs [31], indicating that JMJD2A may serve as an adjuvant target for protein synthesis inhibition in glioma.